Refining Liver Safety Risk Assessment: Application of Mechanistic Modeling and Serum Biomarkers to Cimaglermin Alfa (GGF2) Clinical Trials

    loading  Checking for direct PDF access through Ovid

Excerpt

    loading  Loading Related Articles